Loading
A childhood vaccine against the stomach bacterium behind most stomach cancer would prevent infection for life. One trial in China showed protection; the idea has stalled.
An oral recombinant urease B vaccine showed about 72% efficacy against infection in a Chinese phase 3 in children (published 2015) but was not developed further. Propose a renewed programme of mucosal or mRNA vaccines against urease, CagA and VacA with infection-prevention and gastric precancer endpoints in high-incidence cohorts.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed, Gastric & gastro-oesophageal junction cancer.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed, Gastric & gastro-oesophageal junction cancer.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.